|
|
Changes and significance of myocardial enzyme in the patients with acute cerebrovascular disease |
REN Yongxia |
Department of Clinical Laboratory, Yi′nan People′s Hospital of Linyi City, Shandong Province, Yi′nan 276300, China |
|
|
Abstract Objective To investigate the changes and significance of myocardial enzyme in the patients with acute cere?鄄brovascular disease. Methods The clinical data of 68 patients with acute cerebrovascular disease (acute cerebrova?鄄scular disease group) admitted to People′s Hospital of Linyi City ("our hospital" for short) from August 2015 to December 2016 was analyzed retrospectively, 55 cases of healthy control in our hospital at the same time were selected as normal control group. The levels of aspartate aminotransferase (AST), lactic dehydrogenase (LDH), α-hydroxybutyrate dehydrogenase (α-HBDH), creatine kinas (CK), creatine Kinase Isoenzyme (CK-MB) were detected, and electrocardio?鄄gram was examined. Results The levels of AST, LDH, α-HBDH, CK in the acute cerebrovascular disease group were all higher than those of acute cerebrovascular disease group, the differences were all statistically significant (P < 0.05). There were no statistically significant differences of all indexes of myocardial enzyme between cerebral infarction group and cerebral ischemia group (P > 0.05). According to China stroke scale, the levels of CK in the medium group were signi?鄄ficantly higher than those of light group (P < 0.05), the levels of all indexes of myocardial enzyme in the severe group were all higher than those of light group, the differences were all statistically significant (P < 0.05). The levels of all indexes of myocardial enzyme in the non-conscious disturbance group were all lower than those of conscious disturbance group, the differences were all statistically significant (P < 0.05). There were no statistically significant differences of all indexes of myocardial enzyme between normal electrocardiogram group and abnormal electrocardiogram group (P > 0.05). Conclusion Acute cerebrovascular disease can damage cardiac function, cause the changes of myocardial enzyme, which may be related to the severity of illness, conscious disturbance or not. Myocardial enzyme can be considered as the indexes of judging the severity degree of illness and prognosis of patients with acute cerebrovascular disease.
|
|
|
|
|
[1] 孙彩虹,逢淑申,谭兰,等.急性脑血管病时心肌酶谱的变化[J].中风与神经疾病杂志,2000,17(4):240-241.
[2] 谭勇明,邓树荣,梁涛,等.急性脑血管病并发心肌损害时心肌酶及心电图变化[J].中西医结合心脑血管病杂志,2010,8(1):48-50.
[3] 吴冶夫,谭盛.急性脑血管病对心肌的损害[J].中华神经医学杂志,2005,4(7):708-709.
[4] 毛宇光,沈青.急性脑血管病合并脑心综合征患者的血清肌钙蛋白Ⅰ与心肌酶学变化[J].徐州医学院学报,2011, 31(11):748-749.
[5] 刘明伟,方福平.急性脑血管病并发脑-心综合征的临床研究[J].新乡医学院学报,2012,29(5):362-364.
[6] 黄惠祥.急性脑血管病心电图心肌酶学改变的临床分析[J].河北医学,2013,19(6):903-905.
[7] 甘结友,许启伍,王先放,等.急性脑血管病患者的心肌酶谱分析[J].脑与神经疾病杂志,2005,13(2):132-133.
[8] 中华医学会第四届全国脑血管病学术会议.各类脑血管病诊断要点[J].中华神经内科杂志,1996,29(6):379.
[9] 俸军林,林剑锋,曾爱源,等.急性脑血管病患者心肌酶谱改变及其临床意义[J].临床荟萃,2003,18(13):742-744.
[10] 郭蓉娟,韩刚,王颖辉,等.急性脑血管病与心肌酶谱改变相关性分析[J].北京中医药大学学报,2006,29(3):203-206.
[11] 秦劲松.心电图及心肌酶学改变在急性脑血管病中的临床应用分析[J].中国当代医药,2015,22(22):45-47.
[12] 包广杰. hs-CRP、肌钙蛋白Ⅰ和心肌酶在急性脑血管病中的临床应用[J].中国实用神经疾病杂志,2011,14(17):40,83.
[13] 刘勇,董万利.急性脑血管病合并脑心综合征92例分析[J].中华老年心脑血管病杂志,2006,8(6):397-400.
[14] 朱蕾,董梅,吴纯,等.急性脑血管病患者心肌酶谱监测及临床意义研究[J].现代检验医学杂志,2008,23(1):93-94.
[15] 侯志岭,赵军国,高丽芳,等.急性脑血管病并发脑心综合征的临床分析[J].中国现代医生,2011,49(4):101-102.
[16] 王前友.急性脑血管病并发心肌损害65例临床分析[J].齐齐哈尔医学院学报,2008,29(1):9-11.
[17] 贾红龙.心肌酶在血管性颅内出血患者血清中的水平变化[J].中国医药导报,2009,6(18):13-14.
[18] 周燕利. 50例急性脑血管病并发多脏器功能衰竭的临床观察[J].中国医药科学,2011,1(7):73-74.
[19] 吴晓秋.急性脑血管病患者心肌酶谱变化及临床意义[J].中国实用神经疾病杂志,2008,11(4):110-111.
[20] 江成养.老年急性脑血管病患者心肌酶改变与预后关系探讨[J].国际医药卫生导报,2007,13(17):35-37. |
|
|
|